Lundbeck Pharms Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LUNDBECK PHARMS LLC, and what generic alternatives to LUNDBECK PHARMS LLC drugs are available?
LUNDBECK PHARMS LLC has five approved drugs.
There are seven US patents protecting LUNDBECK PHARMS LLC drugs.
There are seventy-three patent family members on LUNDBECK PHARMS LLC drugs in twenty-one countries.
Summary for Lundbeck Pharms Llc
| International Patents: | 73 |
| US Patents: | 7 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 5 |
Drugs and US Patents for Lundbeck Pharms Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lundbeck Pharms Llc | SABRIL | vigabatrin | TABLET;ORAL | 020427-001 | Aug 21, 2009 | AB | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ||||
| Lundbeck Pharms Llc | ONFI | clobazam | TABLET;ORAL | 202067-003 | Oct 21, 2011 | AB | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ||||
| Lundbeck Pharms Llc | ONFI | clobazam | TABLET;ORAL | 202067-002 | Oct 21, 2011 | AB | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Lundbeck Pharms Llc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Russian Federation | 2008117161 | ⤷ Subscribe |
| Eurasian Patent Organization | 201000828 | ⤷ Subscribe |
| South Korea | 20160033795 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
